%0 Journal Article
%T 1例冠状动脉支架内血栓再形成病例报道
A Case of Coronary Stent Thrombosis Reformation Is Reported
%A 杨琴琴
%J Asian Case Reports in Vascular Medicine
%P 47-49
%@ 2326-3504
%D 2019
%I Hans Publishing
%R 10.12677/ACRVM.2019.73008
%X
冠状动脉粥样硬化性心脏病(Coronary
Atherosclerotic Heart Disease)指冠状动脉发生动脉粥样硬化病变引起血管腔狭窄或阻塞,造成心肌缺血、缺氧或坏死而导致的心脏病,简称冠心病,是威胁人类健康的主要疾病之一。现经皮冠状动脉介入治疗(PCI)是目前冠心病治疗的重要手段,支架内血栓再形成是PCI术治疗过程中罕见但极其危重的并发症。相关研究表明与金属裸支架(baremetalstent, BMS)相比,药物涂层支架(drug-elutingstents,DES)的出现大大降低了支架内血栓再形成发生率,从很大程度上提高冠心病患者的疗效和改善其预后,降至10%以下。相关研究表明ISR的发生是由多种因素造成的,包括个体因素、病变因素、支架选择等因素。术前若能充分的了解并评估ISR的危险因素,可在一定程度上改善冠心病患者临床症状及远期预后。本文将报道1例冠状动脉支架内血栓再形成病例及简述支架危险因素,为降低ISR发生率提供一定参考价值。
Coronary atherosclerotic heart disease (coronary atherosclerotic
heart diseases) refers to coronary artery atherosclerosis lesions which cause
vascular cavity stenosis or occlusion, cause myocardial ischemia, hypoxia or
necrosis caused by heart disease, which is one of the main diseases that threaten
human health. Currently, percutaneous coronary intervention (PCI) is an
important means for the treatment of coronary artery disease, and in-stent
restenosis (ISR) is a rare but extremely critical complication during PCI. Studies
have shown that drug-coated stents (DES) significantly reduce ISR incidence
compared to BMS, significantly improve outcomes and outcomes in patients with
coronary artery disease to less than 10%. Relevant studies have shown that ISR
is caused by many factors, including individual factors, pathological factors,
stent selection and other factors. If risk factors of ISR can be fully
understood and evaluated before operation, clinical symptoms and long-term
prognosis of CHD patients can be improved to
a certain extent. This paper will report a case of coronary stent restenosis
and summarize the risk factors of stent, so as to provide some relevant
value for reducing the incidence of ISR.
%K 冠状动脉支架内血栓形成,病例报道,危险因素
Coronary Stent Thrombosis
%K Case Reports
%K Risk Factors
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=31642